相似文献
1
Staphylococcus aureus TarP: A Brick in the Wall or Rosetta Stone?
Cell Host Microbe. 2019 Feb 13;25(2):182-183. doi: 10.1016/j.chom.2019.01.013.
2
The staphylococcal surface-glycopolymer wall teichoic acid (WTA) is crucial for complement activation and immunological defense against Staphylococcus aureus infection.
Immunobiology. 2016 Oct;221(10):1091-101. doi: 10.1016/j.imbio.2016.06.003. Epub 2016 Jun 15.
3
Methicillin-resistant Staphylococcus aureus alters cell wall glycosylation to evade immunity.
Nature. 2018 Nov;563(7733):705-709. doi: 10.1038/s41586-018-0730-x. Epub 2018 Nov 21.
4
Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.
Infect Immun. 2015 Nov;83(11):4247-55. doi: 10.1128/IAI.00767-15. Epub 2015 Aug 17.
5
Glycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-binding lectin.
J Biol Chem. 2013 Oct 25;288(43):30956-68. doi: 10.1074/jbc.M113.509893. Epub 2013 Sep 17.
6
Wall Teichoic Acid in Staphylococcus aureus Host Interaction.
Trends Microbiol. 2020 Dec;28(12):985-998. doi: 10.1016/j.tim.2020.05.017. Epub 2020 Jun 12.
7
Genetic diversity of wall teichoic acid glycosyltransferases affects immune recognition.
Microb Genom. 2022 Dec;8(12). doi: 10.1099/mgen.0.000902.
8
Biochemical characterization of evasion from peptidoglycan recognition by Staphylococcus aureus D-alanylated wall teichoic acid in insect innate immunity.
Dev Comp Immunol. 2011 Aug;35(8):835-9. doi: 10.1016/j.dci.2011.03.001. Epub 2011 Mar 29.
9
Specific serum Ig recognizing staphylococcal wall teichoic acid induces complement-mediated opsonophagocytosis against Staphylococcus aureus.
J Immunol. 2012 Nov 15;189(10):4951-9. doi: 10.4049/jimmunol.1201294. Epub 2012 Oct 15.
10
[Antibodies to Staphylococcus aureus teichoic acids in the pathogenesis of chronic osteomyelitis].
Zh Mikrobiol Epidemiol Immunobiol. 1987 Sep(9):61-4.
引用本文的文献
1
β-Lactams against the Fortress of the Gram-Positive Bacterium.
Chem Rev. 2021 Mar 24;121(6):3412-3463. doi: 10.1021/acs.chemrev.0c01010. Epub 2020 Dec 29.
本文引用的文献
1
Methicillin-resistant Staphylococcus aureus alters cell wall glycosylation to evade immunity.
Nature. 2018 Nov;563(7733):705-709. doi: 10.1038/s41586-018-0730-x. Epub 2018 Nov 21.
2
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus.
Nature. 2015 Nov 19;527(7578):323-8. doi: 10.1038/nature16057. Epub 2015 Nov 4.
3
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.
Clin Microbiol Rev. 2015 Jul;28(3):603-61. doi: 10.1128/CMR.00134-14.
4
Pathways and roles of wall teichoic acid glycosylation in Staphylococcus aureus.
Int J Med Microbiol. 2014 May;304(3-4):215-21. doi: 10.1016/j.ijmm.2013.10.009. Epub 2013 Nov 1.
5
Glycoepitopes of staphylococcal wall teichoic acid govern complement-mediated opsonophagocytosis via human serum antibody and mannose-binding lectin.
J Biol Chem. 2013 Oct 25;288(43):30956-68. doi: 10.1074/jbc.M113.509893. Epub 2013 Sep 17.
6
Neutrophils versus Staphylococcus aureus: a biological tug of war.
Annu Rev Microbiol. 2013;67:629-50. doi: 10.1146/annurev-micro-092412-155746. Epub 2013 Jul 3.
7
THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.
J Exp Med. 1917 Oct 1;26(4):477-93. doi: 10.1084/jem.26.4.477.
8
The role of nasal carriage in Staphylococcus aureus infections.
Lancet Infect Dis. 2005 Dec;5(12):751-62. doi: 10.1016/S1473-3099(05)70295-4.
9
Enzymatic synthesis and immunochemistry of N-acetylglucosaminylribitol linkages in the teichoic acids of Staphylococcus aureus stains.
J Biol Chem. 1962 Dec;237:3839-41.
10
A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network.
N Engl J Med. 1994 Apr 21;330(16):1107-13. doi: 10.1056/NEJM199404213301602.
Zotero 插件